way 100135 has been researched along with 1-(3-trifluoromethylphenyl)piperazine in 3 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (1-(3-trifluoromethylphenyl)piperazine) | Trials (1-(3-trifluoromethylphenyl)piperazine) | Recent Studies (post-2010) (1-(3-trifluoromethylphenyl)piperazine) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 281 | 7 | 23 |
| Protein | Taxonomy | way 100135 (IC50) | 1-(3-trifluoromethylphenyl)piperazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.57 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.57 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.29 | |
| 5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.61 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.15 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.039 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
| Aguerre, S; Chaouloff, F; Mormede, P | 1 |
| Heidenreich, BA; Napier, TC | 1 |
3 other study(ies) available for way 100135 and 1-(3-trifluoromethylphenyl)piperazine
| Article | Year |
|---|---|
Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine system.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Behavior, Animal; Body Temperature; Dopamine Agonists; Fenfluramine; Indoles; Male; Mice; Motor Activity; Oxindoles; Piperazines; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
GR 127935 and (+)-WAY 100135 do not affect TFMPP-induced inhibition of 5-HT synthesis in the midbrain and hippocampus of Wistar-Kyoto rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Hippocampus; Idazoxan; Ketanserin; Male; Mesencephalon; Mianserin; Nerve Endings; Oxadiazoles; Piperazines; Rats; Rats, Inbred WKY; Rats, Wistar; Reserpine; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Species Specificity; Tryptophan Hydroxylase | 1998 |
Effects of serotonergic 5-HT1A and 5-HT1B ligands on ventral pallidal neuronal activity.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Dose-Response Relationship, Drug; Globus Pallidus; Male; Neurons; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Serotonin Receptor Agonists | 2000 |